Navigation Links
Pharmaceutics International, Inc. (Pii) Expands Drug Formulation and Manufacturing Capabilities with Hot Melt Extrusion Technology
Date:7/27/2011

HUNT VALLEY, Md., July 27, 2011 /PRNewswire/ -- Pharmaceutics International, Inc. (Pii), a leading contract development and manufacturing organization, today announced  that it has added hot melt extrusion (HME) to its portfolio of formulation and process development solutions. The company has purchased a 16mm and an 18mm Leistritz twin screw extruders. This investment enables Pii to carry out feasibility studies, using just a few grams of active pharmaceutical ingredient, to pilot scale cGMP productions for Phase I and II clinical trials using HME.

A well known processing technology, hot melt extrusion offers a number of benefits to optimize drug formulation, including the development of solid dispersions for bioavailability enhancement of poorly soluble compounds and controlled release drug delivery.

"Pii's investment in hot melt extrusion is part of the company's goal of providing our clients with a comprehensive package of bioavailability enhancement capabilities," said Steve King, senior vice president of Pii. "This proven technology further enables us to meet the challenges of poorly soluble compounds and advance our client's compounds through the development pipeline."

In addition to the new hot melt extrusion capability, Pii's solutions for bioavailability enhancement include spray drying, solvent-based fluid bed processing, soft gels and liquid filled hard capsules.

About Pharmaceutics International, Inc.

Pharmaceutics International, Inc. (Pii) is a privately held Drug Delivery Solutions company providing dosage form development and GMP Manufacturing services to the global pharmaceutical industry. Pii's vision is to become the benchmark in pharmaceutical product development outsourcing. Headquartered in Hunt Valley Maryland USA with European facilities in the UK, Pii offers preformulation testing, formulation development and clinical trial material and commercial manufacture of parenteral, solid, semi-so
'/>"/>

SOURCE Pharmaceutics International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmaceutics International Inc. (Pii) Announces Appointment of Rampurna Prasad Gullapalli, Ph.D. as Vice President of Drug Delivery Technologies
2. InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
3. Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc.
4. Chindex International, Inc. Reports First Quarter 2011 Financial Results
5. DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2010
6. Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010
7. VWR International, LLC Acquires AMRESCO Inc.
8. MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.
9. HeartWare International, Inc. Announces Completion of Concurrent Public Offerings of Convertible Senior Notes and Common Stock
10. HeartWare International, Inc. Announces Pricing of Concurrent Public Offerings of Convertible Senior Notes and Common Stock
11. HeartWare International, Inc. Announces Concurrent Public Offerings of Convertible Senior Notes and Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ) has announced ... Application, End-User & by Region - Global Trends & Forecast ... market is projected to reach about $2.5 Million by 2020, ... rising opportunities in countries such as India ... , and Brazil . In 2013, the ...
(Date:7/2/2015)... , July 2, 2015  The Green Exchange, ... the world,s first HIPAA compliant mobile app that connects ... farm-to-table fresh medical marijuana, announced today that their service ... Unlike Eaze, Meadow and more than half a dozen ... last year, Loud Cannabis is unique in that it ...
(Date:7/2/2015)... , July 2, 2015   Decision Resources ... retinal specialists identify less frequent dosing as the ... due to the burden on both patients and ... growth factor (VEGF) injections, which are the current ... abicipar pegol, which is in development for dosing ...
Breaking Medicine Technology:Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 3
... , EXTON, Pa., Dec. 23 BioTrends Research Group, Inc. ... ®: Simponi and Cimzia report. ... 2009. BioTrends also conducted qualitative interviews with a subset (n=20) ... sales and marketing messages being employed to differentiate the products. ...
... , , , , ... /PRNewswire-Asia/ -- China Medicine Corporation,(OTC Bulletin Board: CHME) ("China ... prescription and over the counter pharmaceuticals,traditional Chinese medicines (TCM), ... today announced that Richard P. Wu,has resigned as Chief ...
Cached Medicine Technology:Cimzia Draws Even With Simponi at Six Months Post Launch According to Recent BioTrends Survey 2Cimzia Draws Even With Simponi at Six Months Post Launch According to Recent BioTrends Survey 3China Medicine Announces Changes to Management Team 2China Medicine Announces Changes to Management Team 3
(Date:7/2/2015)... OR (PRWEB) , ... July 02, 2015 , ... Hand ... During the current summer flu season, according to fresh water advocate and radio host ... on the hands. Kleyne cautions that for maximum effectiveness, hand sanitizers must be applied ...
(Date:7/2/2015)... ... 02, 2015 , ... B. E. Smith, the only full-service ... a national chief operating officer recruitment for Nicklaus Children’s Hospital in ... B. E. Smith has recently placed more than 1,000 healthcare executives into organizations. ...
(Date:7/2/2015)... ... 2015 , ... Throughout the month of April, Casey’s General Stores invited customers ... Tuesday, July 7, Casey’s General Stores Chairman and CEO, Bob Myers, will present a ... a national nonprofit dedicated to restoring a sense of self, restoring the family unit, ...
(Date:7/2/2015)... ... July 02, 2015 , ... AvePoint Public Sector, Inc., a ... platforms and devices, today announced it was named the recipient of the 2015 GTRA ... award, given out by the Government Technology Research Alliance (GTRA), was presented June 29 ...
(Date:7/2/2015)... ... July 02, 2015 , ... Catalent Pharma Solutions, the leading ... consumer health products, today announced that it has made two key appointments at ... General Manager at Catalent’s Schorndorf facility, which provides large scale, complex oral solid ...
Breaking Medicine News(10 mins):Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:Casey’s General Stores to Present Donation from “Dog Tag” Campaign to Hope For The Warriors® 2Health News:Casey’s General Stores to Present Donation from “Dog Tag” Campaign to Hope For The Warriors® 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 2Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 4Health News:Catalent Makes Two Key European Appointments in Oral Dose Manufacturing 2
... Arizona State University has used molecular biology tricks to create ... the ones that occurred naturally. ,John ... proteins in a fraction of the three billion years it ... to some surprisingly new lessons on how to optimize proteins ...
... University of Nottingham experts have joined forces with Canadian ... weapons in the fight against food poisoning . ... to develop methods for the control of Campylobacter ... England and Wales, according to the Health Protection Agency. ...
... a child is a uniquely enjoyable process. Why spoil it ... midwives, ask freebirthers . ,Delivering their own babies ... "fearmongering" by doctors and midwives and confidently catch their own ... uses the same hormones as lovemaking - so why would ...
... expectant mothers who smoke during pregnancy may be exposing ... disorder (ADHD), according to a study published in the ... prenatal exposure to smoking in the mothers womb puts ... ,During the course of study, the ...
... years ago, retail pioneer and philanthropist A. Alfred Taubman lost ... fatal disease thats better known as Lou Gehrigs disease or ... Sen. Jacob Javits slowly succumb to the nerve-killing condition has ... him to support ALS research at the University of Michigan ...
... seeking to prosecute director Michael Moore for taking volunteers on ... admission from New Yorks civic authorities. ,City's chief ... from the twin towers contributed to the death of Felicia ... Sept. 11 as she ran from her office a block ...
Cached Medicine News:Health News:Experts to Develop New Weapons Against Food Poisoning 2Health News:Experts to Develop New Weapons Against Food Poisoning 3Health News:Delivering Baby, the Natural Way. 2Health News:$5M Gift Will Attack Lou Gehrig's Disease 2Health News:$5M Gift Will Attack Lou Gehrig's Disease 3Health News:Death from Exposure to WTC Dust Confirmed 2
... hydrophilic acrylic IOL is the newest advance ... with the patient and surgeon in mind. ... optic polymerically crosslinked with PMMA haptics to ... excellent visual performance and biocompatibility. The high ...
... : the 1st monobloc hard ... an exclusive and patented process ... designed the first single piece ... the FZ60. This technology warrantes ...
TRIPODE Hydrophilic Acrylic Lens....
One piece multifocal acrylic intraocular lens....
Medicine Products: